Adjunctive Treatments for the Prevention of Radiotherapy-Induced Mucositis
Status:
Active, not recruiting
Trial end date:
2023-12-30
Target enrollment:
Participant gender:
Summary
Radiation therapy (RT) is used in at least 50% of cancer patients and is critical in treating
and palliating tumor-related symptoms. Normal tissue radiation toxicity remains an
overwhelming obstacle in treating cancer patients with localized tumors.
Mucositis is the inflammation and ulceration of the oral and gastrointestinal mucosa observed
with different cancer therapies. Oral mucositis is a common, severe, and debilitating
complication of RT occurring several days to weeks after RT initiation.